CRUK RadNet Glasgow Centre

On Friday 20th March 2026 we were proud to be able to host the CRUK RadNet Glasgow+ community for our 6th annual symposium, entitled 'Embracing New Technologies and Exploring Socioeconomic Factors.' It was a great opportunity to get many members of the network together in person.

The morning session began with a remote welcome from CRUK RadNet Glasgow+ Director Anthony Chalmers. Unfortunately, Anthony was unable to attend due to a recent injury. He was much missed and we all wish him a speedy recovery.

Session one focused on exploring socioeconomic determinants of radiotherapy outcomes. We were delighted to have University of Glasgow's Petra Meier as one of our key note speakers. Petra kicked off session one with a very engaging and relevant talk, 'University of Glasgow Healthy and Equitable Futures.' We had excellent PPI representation from Rachel Brooker and Linda Galbraith who gave a talk on 'Completion and socioeconomic deprivation.' This was followed by a wonderful delineation of 'The challenge of inequalities across the head and neck cancer continuum,' from David Conway, one of our Health Inequalities theme leads.

Claire Paterson and Catriona Douglas then gave an overview of their work for Glasgow Head and Neck Cancer group, followed by a brilliant talk by Katy Fair asking, 'Are clinical trial participants representative of the head and neck cancer population?' Our last talk before lunch was by Stephy Anderson and Ronan Valentine, discussing the use of 'BARITONE Imaging Data.'

In session 2 we saw talks focusing on embracing new technologies. Jonny Bowden started our afternoon session with a brilliant talk on 'R&D in radiotherapy physics' which was then followed by a very interesting presentation 'Introducing Ethos and Hypersight' from Ross Carruthers. Dave Colville gave a comprehensive talk on the use of 'Total body PET and MRT at Glasgow.'

We are grateful to Professor Philippe Lambin who travelled all the way from Amsterdam to deliver a wonderful key note on 'The history and evolution of radiomics.' This was followed by another international guest, Zuhir Bodalal who also travelled from the Netherlands to give a talk on 'MRI Radiogenomics in H&N Cancers.' Kevin Blyth gave a very engaging talk on 'Automated Mesothelioma Segmentation,' followed by a great presentation from Alge Bloom discussing, 'Living Lab Radiomics.'

Alongside a range of brilliant speakers we had a vibrant poster session from 11 of our RadNet Glasgow+ colleagues. Posters included:

• Glioblastoma stem cell-specific sensitivity to temozolomide by Brenna Young
• Targeting carnitine metabolism and fatty acid oxidation to enhance radiotherapy responses in locally advanced NSCLC by Adam Peters
• The effects of the COVID-19 pandemic on survival outcomes of head and neck cancer squamous cell carcinomas in the West of Scotland: A retrospective cohort study by Craig Smith
• Mapping spatial features of the pancreatic cancer stroma in preclinical therapy models by Jayathilake Pahala Gedara
• Modification of the adverse effects of radiotherapy on the normal brain with DNA damage response inhibitors by Mark Jackson
• Mitochondrial reprogramming and function in response to radiotherapy by Vanessa Xavier
• Topology-Led Single-Cell Analysis Reveals a Ferritin-Linked Metal-Lysosome Axis in Irradiated Adult Brain Microglia Modulated by ATM Inhibition by Marc Haniford
• RT induces adaptation of PDAC cells to allow progression through the acute oxidative barrier encountered during early lung colonisation by Yuefan Sun
• Radiotherapy-induced stress adaptation and antitumour immunity in metastatic group 3 medulloblastoma by Eliot Mason
• Investigating the potential of BH3-mimetics as radiosensitisers in a screen of solid cancers by Kirsteen Campbell
• Investigating ubiquitin signalling in the radiotherapy response of glioblastoma by Joseph Rowland

We would like to extend our sincere thanks to all of the speakers and to David Lewis who stepped in last minute to chair, and to Gareth Inman who delivered the closing remarks. A special thanks as well to all of our attendees.